Cargando…

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study

BACKGROUND: VIRTUE was a prospective, observational study assessing the effectiveness and safety of vildagliptin vs sulfonylureas (SUs) (both as monotherapy and in combination with metformin) in patients with type 2 diabetes mellitus who fasted during Ramadan. A post hoc analysis was carried out to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassoun, Ahmed AK, Pathan, Md Faruque, Medlej, Rita C, Alarouj, Monira, Shaltout, Inass, Chawla, Manoj S, Knap, Ditte, Vaz, Julius A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968856/ https://www.ncbi.nlm.nih.gov/pubmed/27555791 http://dx.doi.org/10.2147/DMSO.S103692

Ejemplares similares

The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study
por: Al-Arouj, M, et al.
Publicado: (2013)

Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study
por: Khattab, Mohamed, et al.
Publicado: (2016)

Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS)
por: Hassanein, Mohamed, et al.
Publicado: (2017)

Sexuality in the Muslim community during Ramadan
por: Sayari, N., et al.
Publicado: (2022)

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
por: Das, Sambit, et al.
Publicado: (2021)

The Complex Etiology of Childhood Obesity in Arabs Is Highlighted by a Combination of Biological and Socio-Economic Factors
por: Elkum, Naser, et al.
Publicado: (2019)

Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients
por: Aziz, Kamran MA
Publicado: (2015)

Muslim patients in Ramadan: A review for primary care physicians
por: Abolaban, Heba, et al.
Publicado: (2017)

Diabetes among Muslims during Ramadan: A narrative review
por: Ochani, Rohan Kumar, et al.
Publicado: (2023)

Effects of Fasting During Ramadan Month on Cognitive Function in Muslim Athletes
por: Tian, Ho-Heng, et al.
Publicado: (2011)

Fasting among Muslim cancer patients during the holy month of Ramadan
por: Zeeneldin, Ahmed A., et al.
Publicado: (2012)

Ramadan: the month of fasting for muslim and social cohesion—mapping the unexplored effect
por: Shalihin, Nurus, et al.
Publicado: (2022)

Thyroid diseases and Ramadan
por: Raza, Syed A., et al.
Publicado: (2012)

Comment on: Fasting among Muslim cancer patients during the holy month of Ramadan
por: Karagöz, Ahmet, et al.
Publicado: (2014)

Vildagliptin/metformin: Lactic acidosis and hypoglycaemia: case report
Publicado: (2022)

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
por: Jeon, Hyun Jeong, et al.
Publicado: (2011)

Self-Care by Muslim Women during Ramadan Fasting to Protect Nutritional and Cardiovascular Health
por: López-Bueno, Marta, et al.
Publicado: (2021)

Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderly
por: Sicras-Mainar, Antoni, et al.
Publicado: (2014)

Diabetic emergencies including hypoglycemia during Ramadan
por: Ahmad, Jamal, et al.
Publicado: (2012)

Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study
por: Halimi, Serge, et al.
Publicado: (2013)

Metformin Sustained-Release and Vildagliptin Fixed-Dose Combination for Optimizing Glycemic Control: A Review with Real-World Case Reports
por: Chawla, Manoj, et al.
Publicado: (2023)

Diabetes mellitus in the young: Gliptins or sulfonylurea after metformin?
por: Muthukrishnan, J., et al.
Publicado: (2012)

Effect of Ramadan intermittent fasting on selective fitness profile parameters in young untrained Muslim men
por: Roy, Anindita Singha, et al.
Publicado: (2015)

SUN-LB126 Real-World Safety and Effectiveness of Insulin Glargine 300 U/ML (Gla-300) in People With Type 2 Diabetes Who Fast During Ramadan
por: Hassanein, Mohamed, et al.
Publicado: (2020)

Bioequivalence Studies of New Generic Formulations of Vildagliptin and Fixed-Drug Combination of Vildagliptin and Metformin Versus Respective Originator Products in Healthy Volunteers
por: Schnaars, Yvonne, et al.
Publicado: (2022)

The balancing of virtues—Muslim perspectives on palliative and end of life care: Empirical research analysing the perspectives of service users and providers
por: Suleman, Mehrunisha
Publicado: (2022)

Preparing muslims with diabetes mellitus for Ramadan fasting in Singapore: a clinical approach and review of current practice
por: Zainudin, Sueziani Binte, et al.
Publicado: (2021)

Guidelines regarding management of adrenal insufficiency in the Holy month of Ramadan
por: Siddiqi, Sheelu S., et al.
Publicado: (2012)

Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in “Real-World” Management of Type 2 Diabetes Mellitus: The G-FORCE Study
por: Van Gaal, Luc, et al.
Publicado: (2019)

Recommendations for management of diabetes and its complications during Hajj (Muslim pilgrimage)
por: Ibrahim, Mahmoud, et al.
Publicado: (2018)

Islamic virtues and end‐of‐life decisions in clinical practice: A commentary on Mehrunisha Suleman, ‘The Balancing of Virtues—Muslim Perspectives on End of Life Care: Empirical research analysing the perspectives of service users and providers’
por: Oakley, Justin
Publicado: (2022)

Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study
por: Mohan, Viswanathan, et al.
Publicado: (2021)

The virtues
por: Geach, P. T. (Peter Thomas), 1916-2013
Publicado: (1977)

Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin
por: Al Omari, Mousa, et al.
Publicado: (2016)

Comparison of Safety and Efficacy of Glimepiride-Metformin and Vildagliptin- Metformin Treatment in Newly Diagnosed Type 2 Diabetic Patients
por: Kumar, Surendra
Publicado: (2021)

Letter to the Editor: The first Ramadan during COVID-19 pandemic: 1.8 billion Muslims should fast or not?
por: Mosaferchi, Saeedeh, et al.
Publicado: (2020)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
por: Ved, Paresh, et al.
Publicado: (2012)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
por: Ved, Paresh, et al.
Publicado: (2013)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus’
por: Mundra, Vishal
Publicado: (2012)

Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma
por: Toomey, Paul, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_db6tmgu0d4aa6m0dd0at6jie13